WebCyclo Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CYTH updated stock price target summary. WebApr 4, 2024 · CYTH Overview Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company developing cyclodextrin-based products for the treatment of various... read more Zen Score Total Score Score Breakdown – Industry Average ( 28) You've viewed Zen Score for 10/10 free stocks.
Cyclo Therapeutics Stock (NASDAQ:CYTH), Quotes and News …
WebMar 31, 2024 · Free-Float. 77,5%. More Financials. Company. Cyclo Therapeutics, Inc. is a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The Company’s lead drug candidate, Trappsol Cyclo (hydroxypropyl beta cyclodextrin) as a treatment for Niemann-Pick Type C disease (NPC). WebApr 6, 2024 · According to the issued ratings of 1 analysts in the last year, the consensus rating for Cyclo Therapeutics stock is Hold based on the current 1 hold rating for CYTHthe . Learn more on CYTH's analyst rating history. Do Wall Street analysts like Cyclo Therapeutics more than its competitors? eddie rabbitt i can\\u0027t help myself
CYTH Cyclo Therapeutics Inc - Ordinary Shares - Class A
WebFeb 17, 2024 · RTTNews • Nov 17, 2024 Cyclo Therapeutics Adds 5% After Submitting IND To Evaluate Trappsol Cyclo For Alzheimer's Disease RTTNews • Nov 16, 2024 See All News About Cyclo Therapeutics, Inc. 6714 NW... WebMar 27, 2024 · The smoke has made the air quality in the DMV region slightly worse, but it is not unsafe to breathe, according to NASA scientists and air quality expert Ryan Stauffer. WebApr 11, 2024 · CYTH has decreased by -75.37% in the past year and price targets may not have had time to catch up. Stock Price Forecast. According to 6 stock analysts, the average 12-month stock price forecast for CYTH stock is $5.1, which predicts an increase of 636.46%. The lowest target is $5.05 and the highest is $5.25. eddie rabbitt hearts on fire lyrics